Jennifer D. Choo (3/22/2006)
Project: Orthokeratology Corneal Changes and their Implications
Orthokeratology is a vision correction technique where patients wear specially designed contact lenses overnight to reshape the cornea. The Vision CRC is investigating the physiological changes that occur during orthokeratology to help understand the risks and best practice. Full Story
|
Mohamed Dirani (3/2/2006)
Project: The Heritability of Myopia – A Twin Study
Twin studies have supported a genetic basis to myopia by reporting a higher similarity for myopia status in identical twins compared to non-identical twins. We have examined over 1200 twins to investigate refractive error. Full Story
|
Heathcote R Wright (1/16/2006)
Project: Trachoma in Northern Australia: A public health problem?
Trachoma is a leading cause of infectious blindness affecting Aboriginal communities in remote areas. This project is examining whether the use of swimming pools may reduce the incidence of the disease. Full Story
|
Ramkumar Ramamirtham (12/14/2005)
Project: Wave aberrations in rhesus monkeys
Studying developmental changes in monkeys will provide new insights into the origins of myopia, and may lead to the development of methods of prevention. Full Story
|
Lisa Keay (9/11/2005)
Project: Public health impact of contact lens related microbial keratitis
The Australian and New Zealand Microbial Keratitis Study investigated for the first time how many contact lens-related infections occur with different lens types, and risk factors associated with infection.
Full Story
|
Isabelle Jalbert (9/22/2005)
Project: Effects of varying oxygen transmissibility contact lenses on the corneal stroma and investigation of the underlying cellular mechanisms
Studies at the Vision CRC have used a confocal microscope to examine the stroma of contact lens wearers, looking at the effect of lens wear on this part of the cornea. Full Story
|
Mahesh Bandara (8/22/2005)
Project: Effects of non-steroidal anti-inflammatory agents on biofilm formed by bacteria
New Vision CRC research shows that the active ingredient in aspirin can stop bacteria taking hold on biopolymers and can also combat infection. Mahesh Bandara recently completed the research as part of his PhD. Full Story
|
